What is the address of Dr. GIGASE-Dr. VAN MALDEGHEM?

The registered office of Dr. GIGASE-Dr. VAN MALDEGHEM is located at Zandvlietse Dorpstraat 48, 2040 Antwerpen.

Is Dr. GIGASE-Dr. VAN MALDEGHEM still active?

Yes. According to the CBE (2 October 2026) Dr. GIGASE-Dr. VAN MALDEGHEM is active, legal situation “Normale toestand”, started on 20 February 2006.

Is Dr. GIGASE-Dr. VAN MALDEGHEM registered on Peppol?

Yes, Dr. GIGASE-Dr. VAN MALDEGHEM is registered on the Peppol network with ID 0208:0879470096.

What is the enterprise number of Dr. GIGASE-Dr. VAN MALDEGHEM?

The enterprise number of Dr. GIGASE-Dr. VAN MALDEGHEM is BE0879470096.

When was Dr. GIGASE-Dr. VAN MALDEGHEM founded?

Dr. GIGASE-Dr. VAN MALDEGHEM was founded on 20 February 2006.

Who are the directors of Dr. GIGASE-Dr. VAN MALDEGHEM?

According to the 2024 annual accounts, the directors of Dr. GIGASE-Dr. VAN MALDEGHEM are: Geertrui Van Maldeghel, Pierre Gigase.

Is Dr. GIGASE-Dr. VAN MALDEGHEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 February 2006; 3 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did Dr. GIGASE-Dr. VAN MALDEGHEM make in 2024?

Dr. GIGASE-Dr. VAN MALDEGHEM posted a profit after taxes of € 211,489 in financial year 2024.

What is the revenue of Dr. GIGASE-Dr. VAN MALDEGHEM?

As a small company, Dr. GIGASE-Dr. VAN MALDEGHEM is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 331,644.

Dr. GIGASE-Dr. VAN MALDEGHEM (Private Limited)

Dossier Dr. GIGASE-Dr. VAN MALDEGHEM, printed on 2 October 2026 from databakkes.be/en/0879470096/dr-gigase-dr-van-maldeghem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. GIGASE-Dr. VAN MALDEGHEM from Antwerpen, company number BE0879470096, closed financial year 2024 with a result of € 211,489 after tax. For that financial year Dr. GIGASE-Dr. VAN MALDEGHEM recorded a gross margin of € 331,644 and equity of € 1.9 million. Compared with financial year 2022, the result moved from € 205,406 to € 211,489. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 31, 2025.

What it is worth Growing

€ 1.9 million

▲ 26% vs 2022

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 211,489

▲ 3% vs 2022

Profit after tax over the fiscal year.

Cash in the bank

€ 375,440

▲ 115% vs 2022

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 1.9 million.

People and assets in 2024

Vehicles and equipment

€ 2,264

▼ 90% vs 2022

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 253,554

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 39,267

▲ € 32,554 vs 2022

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,467

▲ 60% vs 2022

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2024	Change 2022 → 2024
Revenue	€ 467,313 Revenue 2021: € 467,313 First fiscal year in the series	-	-
Gross margin	€ 311,779 Gross margin 2021: € 311,779 First fiscal year in the series	€ 319,080 Gross margin 2022: € 319,080 ▲ 2% vs 2021 (€ 311,779) Favourable step	€ 331,644 Gross margin 2024: € 331,644 ▲ 4% vs 2022 (€ 319,080) Favourable step	▲ 4%
Profit after taxes	€ 191,463 Profit after taxes 2021: € 191,463 First fiscal year in the series	€ 205,406 Profit after taxes 2022: € 205,406 ▲ 7% vs 2021 (€ 191,463) Favourable step	€ 211,489 Profit after taxes 2024: € 211,489 ▲ 3% vs 2022 (€ 205,406) Favourable step	▲ 3%
Equity	€ 1,292,081 Equity 2021: € 1,292,081 First fiscal year in the series	€ 1,497,486 Equity 2022: € 1,497,486 ▲ 16% vs 2021 (€ 1,292,081) Favourable step	€ 1,883,115 Equity 2024: € 1,883,115 ▲ 26% vs 2022 (€ 1,497,486) Favourable step	▲ 26%
Total debts	€ 273,689 Total debts 2021: € 273,689 First fiscal year in the series	€ 286,590 Total debts 2022: € 286,590 ▲ 5% vs 2021 (€ 273,689) Unfavourable step	€ 319,845 Total debts 2024: € 319,845 ▲ 12% vs 2022 (€ 286,590) Unfavourable step	▲ 12%
Cash	€ 128,219 Cash 2021: € 128,219 First fiscal year in the series	€ 174,356 Cash 2022: € 174,356 ▲ 36% vs 2021 (€ 128,219) Favourable step	€ 375,440 Cash 2024: € 375,440 ▲ 115% vs 2022 (€ 174,356) Favourable step	▲ 115%
Land & buildings	€ 321,000 Land & buildings 2021: € 321,000 First fiscal year in the series	€ 321,000 Land & buildings 2022: € 321,000 Unchanged (€ 321,000) Unchanged	€ 321,000 Land & buildings 2024: € 321,000 Unchanged (€ 321,000) Unchanged
Retained profit	€ 1,273,481 Retained profit 2021: € 1,273,481 First fiscal year in the series	€ 1,478,886 Retained profit 2022: € 1,478,886 ▲ 16% vs 2021 (€ 1,273,481) Favourable step	€ 1,854,115 Retained profit 2024: € 1,854,115 ▲ 25% vs 2022 (€ 1,478,886) Favourable step	▲ 25%
Bank debt	€ 253,554 Bank debt 2021: € 253,554 First fiscal year in the series	€ 253,554 Bank debt 2022: € 253,554 Unchanged (€ 253,554) Unchanged	€ 253,554 Bank debt 2024: € 253,554 Unchanged (€ 253,554) Unchanged
Balance sheet total	€ 1,565,770 Balance sheet total 2021: € 1,565,770 First fiscal year in the series	€ 1,784,076 Balance sheet total 2022: € 1,784,076 ▲ 14% vs 2021 (€ 1,565,770) Unchanged	€ 2,202,960 Balance sheet total 2024: € 2,202,960 ▲ 23% vs 2022 (€ 1,784,076) Unchanged	▲ 23%

Key figures of Dr. GIGASE-Dr. VAN MALDEGHEM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. GIGASE-Dr. VAN MALDEGHEM?

What happened at Dr. GIGASE-Dr. VAN MALDEGHEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 31, 2025 New annual accounts for financial year 2024: profit of € 211,489 (▲ 3% vs 2022). filed late Source: NBB ↗
Feb 20, 2006 Start of the company according to the CBE. KBO
Feb 7, 2006 New establishment in Antwerpen. KBO

In short

From € 191,463 profit in 2021 to € 211,489 profit in 2024.

Paid € 274,179 in corporate taxes since 2021.

Best year ever: 2024, with € 211,489 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. GIGASE-Dr. VAN MALDEGHEM? We notify you, reason included.

Follow Dr. GIGASE-Dr. VAN MALDEGHEM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Geertrui Van Maldeghel Pierre Gigase

Dr. GIGASE-Dr. VAN MALDEGHEM

Behind Dr. GIGASE-Dr. VAN MALDEGHEM are Geertrui Van Maldeghel and Pierre Gigase.

See the full network in the app

Directors

According to the 2024 annual accounts

Geertrui Van Maldeghel

Director

Pierre Gigase

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Zandvlietse Dorpstraat 48

2040 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Huisartsen-Navormingsinstituut

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0879.470.096
VAT number: BE 0879.470.096
Registered office: Zandvlietse Dorpstraat 48, 2040 Antwerpen
Names & denominations: Dr. GIGASE-Dr. VAN MALDEGHEM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 February 2006
Peppol: Active · Active since 5 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗